AIM
DGX icon

Artemis Investment Management’s Quest Diagnostics DGX Stock Holding History

Artemis Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$78M Sell
334,585
-133,336
-28% -$30.8M 0.68% 59
2026
Q2 		$99.2M Buy
467,921
+20,647
+5% +$4.05M 0.88% 40
2026
Q1 		$87.7M Sell
447,274
-13,451
-3% -$2.61M 0.93% 37
2025
Q4 		$79.9M Buy
460,725
+29,084
+7% +$5.3M 0.97% 32
2025
Q3 		$82.3M Buy
431,641
+208,193
+93% +$36.9M 1.02% 30
2025
Q2 		$40.1M Buy
+223,448
New +$38.8M 0.51% 72

Other funds holding DGX

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Artemis Investment Management's DGX Position: Q3 2026 in Review

Artemis Investment Management reduced its Quest Diagnostics (DGX) stake by 28% in Q3 2026, selling an estimated $30.8M and leaving 334,585 shares worth $78M. The position accounts for 0.68% of the portfolio, ranked #59.

Artemis Investment Management first reported a position in DGX in Q2 2025 and has held it in 6 quarters since. The position peaked at $99.2M in Q2 2026. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Artemis Investment Management held 334,585 shares of Quest Diagnostics worth $78M as of Q3 2026.
  • Artemis Investment Management sold 133,336 Quest Diagnostics shares in Q3 2026, an estimated $30.8M.
  • Quest Diagnostics made up 0.68% of Artemis Investment Management's portfolio in Q3 2026, its #59 holding.
  • Artemis Investment Management first reported a position in Quest Diagnostics in Q2 2025 and has held it in 6 quarters since.
  • Artemis Investment Management's Quest Diagnostics position peaked at $99.2M in Q2 2026.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Artemis Investment Management's 13F filing for Q3 2026, filed 8 Oct 2026.